Niemann Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Niemann Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-221,987	Closed	-$17.4M	–	20
2015 Q2	$17.4M	Sell	221,987 -29,675	-12%	-$2.31M	12.41%	2
2015 Q1	$19.2M	Sell	251,662 -8,308	-3%	-$611K	12.98%	2
2014 Q4	$17.3M	Sell	259,970 -10,488	-4%	-$698K	12.3%	1
2014 Q3	$17.2M	Sell	270,458 -9,218	-3%	-$569K	12.34%	3
2014 Q2	$17.1M	Sell	279,676 -24,061	-8%	-$1.39M	11.68%	1
2014 Q1	$17.2M	Buy	303,737 +2,643	+0.9%	+$150K	11.71%	1
2013 Q4	$16.1M	Sell	301,094 -13,217	-4%	-$661K	11.1%	1
2013 Q3	$14.5M	Sell	314,311 -19,712	-6%	-$899K	10.41%	2
2013 Q2	$14.1M	Buy	+334,023	New	+$13.9M	11.63%	1

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Niemann Capital Management's PJP Position: Q3 2015 in Review

Niemann Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2015, closing a stake of 221,987 shares — an estimated $17.4M sold.

Niemann Capital Management first reported a position in PJP in Q2 2013 and held it in 9 quarters. The position peaked at $19.2M in Q1 2015. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

Niemann Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Niemann Capital Management sold 221,987 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $17.4M.
Niemann Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 9 quarters.
Niemann Capital Management's Invesco Pharmaceuticals ETF position peaked at $19.2M in Q1 2015.
106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on Niemann Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.